本页面由Tiger Trade Technology Pte. Ltd.提供服务

阿诺医药

11.92
+0.36003.11%
盘后11.920.00000.00%16:10 EDT
成交量:2.42万
成交额:28.60万
市值:7.68亿
市盈率:-10.73
高:12.07
开:11.56
低:11.53
收:11.56
52周最高:17.25
52周最低:0.8786
股本:6,439.79万
流通股本:4,616.92万
量比:0.11
换手率:0.05%
股息:- -
股息率:- -
每股收益(TTM):-1.1111
每股收益(LYR):-1.1111
净资产收益率:-414.01%
总资产收益率:-42.21%
市净率:-92.24
市盈率(LYR):-10.73

数据加载中...

2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/10

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/09/16

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/05/10

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2025/05/01

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/02/14

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2025/01/27

SEC问询函

Form CORRESP - Correspondence
2025/01/02

SEC问询函

Form CORRESP - Correspondence
2024/05/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/19

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/04

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/31

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/27

SEC问询函

Form CORRESP - Correspondence
2023/09/27

SEC问询函

Form CORRESP - Correspondence
2023/09/27

SEC问询函

Form CORRESP - Correspondence